Anna Klimovich | Biochemistry | Young Scientist Award

Dr. Anna Klimovich | Biochemistry | Young Scientist Award 

Dr. Anna Klimovich | G.B. Elyakov Pacific Institute of Bioorganic Chemistry Far-Eastern Branch of the Russian Academy of Sciences | Russia

Dr. Anna Klimovich is a PhD candidate in biochemistry with a decade of experience as a research fellow, specializing in the investigation of biologically active compounds derived from marine organisms of the Far Eastern and tropical seas using advanced experimental models of human pathologies in laboratory animals. She works as a research assistant in the Laboratory of Molecular Pharmacology and Biomedicine at the Pacific Institute of Bioorganic Chemistry, contributing extensively to fundamental and applied biomedicine. Her scientific portfolio includes 40 publications indexed in Web of Science and Scopus, supported by 199 citations across 162 documents and an h-index of 8, reflecting her strong research impact. She has completed seven research projects and is an inventor or co-inventor on seven patents focused on bioactive marine compounds and their therapeutic potential. Her research areas span biology, biochemistry, biomedicine, natural biologically active substances, and preclinical trials, with collaborative work involving Far Eastern Federal University in Vladivostok. Dr. Klimovich has contributed significantly to the characterization of marine peptides and metabolites, including the sea anemone peptide HCRG21, which exhibits analgesic, anti-inflammatory, and anxiolytic activities and demonstrates therapeutic potential for allergic dermatitis and psoriasis. She has also studied the peptide HCIQ2c1 with anti-inflammatory and neuroprotective properties, and the sea anemone peptides Hcr 1b-2, Hcr 1b-4, and AnmTX Sco 9a-1, which show strong anxiolytic, anti-inflammatory, and analgesic effects. Her work further includes discovering the antidiabetic and antiglycemic activities of the peptide Mgf, evaluating antimicrobial and antitumor effects of phenylphascaplysine alkaloid derivatives, and identifying the ability of triterpene glycosides from sea cucumbers—Cucumarioside A0-1, Djakonovioside A—and the peptide Hct-S3 to inhibit tumor metastasis. Additionally, she contributed to demonstrating that asterripeptides A–C from marine fungi possess therapeutic activity in treating infected wounds. Her research advances marine-derived therapeutic discoveries with high relevance to pharmacology, biotechnology, and translational biomedicine.

Profiles: Scopus | Orcid

Featured Publications

Klimovich, A., Kvetkina, A., Deryavko, Y., Priymenko, N., Popkova, D., Bystritskaya, E., Isaeva, M., Gladkikh, I., Sintsova, O., & Leychenko, E. (2025). TRPV1 blocker, peptide HCRG21 from sea anemone Heteractis magnifica, exhibits effectiveness in psoriasis and dermatitis in in vivo models. International Journal of Molecular Sciences, 26(21), 10644. https://doi.org/10.3390/ijms262110644

Klimovich, A. A., Chingizova, E. A., Pislyagin, E. A., Kotelnikov, V. N., & Shperling, I. A. (2025). Eksperimental’no-funktsional’naya otsenka ranozazhivlyayushchey aktivnosti gidrogelya na osnove karboksimetiltsellyulozy s biologicheski aktivnymi veshchestvami iz gidrobiontov Tikhogo okeana pri termicheskom ozhoge [Experimental and functional evaluation of the wound-healing activity of a carboxymethylcellulose-based hydrogel with bioactive substances from Pacific Ocean hydrobionts in a thermal burn model]. Clinical and Fundamental Medicine, 2, 5–12. https://doi.org/10.24866/3033-5485/2025-2/5-12

Zhidkov, M. E., Smirnova, P. A., Grammatikova, N. E., Isakova, E. B., Shchekotikhin, A. E., Styshova, O. N., Klimovich, A. A., & Popov, A. M. (2025). Comparative evaluation of the antibacterial and antitumor activities of marine alkaloid 3,10-dibromofascaplysin. Marine Drugs, 23(2), 68. https://doi.org/10.3390/md23020068

Klimovich, A. A., Kvetkina, A. N., Deryavko, Y. V., Priymenko, N. A., & Leychenko, E. V. (2024). Peptide TRPV1 channel blocker, HCRG21, effectively suppresses inflammation in a calcipotriol-induced allergic dermatitis model. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 18, (Issue no. pending). https://doi.org/10.1134/S1990750824601127

Pavlenko, A. P., Klimovich, A. A., Yurchenko, E. A., Kvetkina, A. N., & Leychenko, E. V. (2024). Sea anemone Heteractis magnifica toxin Hct-S3 suppresses the migration of solid Ehrlich adenocarcinoma cells inoculated into BALB/C mice. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 18, (Issue no. pending). https://doi.org/10.1134/S1990750824601206

Klimovich, A. A., Styshova, O. N., Popov, A. M., Moskvina, T. V., Tsybulsky, A. V., Derunov, D. A., & Stonik, V. A. (2020). Experimental study of therapeutic efficacy of the topical preparation “Kourochitin” in skin allergy. Letters in Drug Design & Discovery, 17(10), 1234–1241.

Prof. Dr. Antonio Rescifina | Chemistry | Best Researcher Award

Prof. Dr. Antonio Rescifina | Chemistry | Best Researcher Award

University of Catania, Italy.

Prof. Dr. Antonio Rescifina, born on December 23, 1964, in Messina, Italy, is a distinguished researcher and professor in Organic Chemistry. He currently serves as a Full Professor in the Department of Pharmaceutical Sciences at the University of Catania, where he has been a member of the faculty since 1996. His research focuses on the synthesis of organic compounds with applications in pharmaceuticals, environmental chemistry, and materials science.

Profile

Scopus

Orcid

Education 🎓

Prof. Rescifina holds a degree in Chemistry and Pharmaceutical Technology from the University of Messina (1989), with honors. He later obtained another degree in Pharmacy (1991) and completed a Ph.D. in Chemical Sciences with a specialization in Organic Chemistry from the University of Catania (1995).

Experience 💼

Prof. Rescifina has had an extensive career in research and teaching. He worked as a researcher at the University of Catania and the University of Messina before becoming a professor. Over the years, he has contributed significantly to scientific advancements in organic chemistry, working on numerous projects funded by both national and international organizations. His roles have included being a scientific coordinator of various research projects.

Research Interests 🔬

Organic Chemistry and Pharmaceutical Applications
Dr. Yucra's work primarily focuses on the synthesis of novel chemical compounds for pharmaceutical and industrial applications. His research aims to create more efficient, cost-effective, and sustainable solutions to current challenges in these sectors.

Carbon Dioxide Decarbonization & Valorization
He is committed to developing innovative carbon dioxide decarbonization and valorization processes, which aim to transform CO₂ from a harmful greenhouse gas into valuable industrial products, contributing to environmental sustainability.

Green Chemistry
Dr. Yucra emphasizes green chemistry principles, working on solutions that minimize environmental impact, enhance energy efficiency, and reduce the use of toxic chemicals, all while maintaining effective chemical processes.

Pharmaceutical Nanostructures
In his work on pharmaceutical nanostructures, he explores the development of nanoscale materials that can be used for targeted drug delivery, improving the effectiveness of treatments while reducing side effects.

Supramolecular Catalysis
His interest in supramolecular catalysis focuses on creating catalysts that work through non-covalent interactions, leading to more efficient and selective chemical reactions, with potential applications in pharmaceuticals and green chemistry.

Sustainable Chemistry Materials
Finally, Dr. Yucra is involved in the design and development of innovative materials for sustainable chemistry, aiming to create alternatives to traditional chemical processes that are more sustainable, eco-friendly, and economically viable.

.

Awards 🏆

Prof. Rescifina's work has earned him national recognition, including the prestigious Abilitazione Scientifica Nazionale (National Scientific Qualification) for Full Professor in 2018.

His research contributions have been acknowledged in various funded projects and prestigious conferences.

Selected Publications 📚

Designing a Monolithic Photo-Fenton Catalyst Using a Fungal Hydroxypyrone Metabolic Derivative
Materials Today Chemistry
March 2025 | Journal article
Contributors: Elisabetta Grazia Tomarchio, Valentina Giglio, Chiara Zagni, Sabrina Carola Carroccio, Vincenzo Paratore, Guglielmo Guido Condorelli, Giuseppe Floresta, Sandro Dattilo, Antonio Rescifina.

Efficient Green Solvent-Free CO2/Epoxide Cycloaddition Catalyzed by a β-Cyclodextrin-Imidazolium-Based Ionic Liquid
Journal of Industrial and Engineering Chemistry
March 2025 | Journal article
Contributors: Elisabetta Grazia Tomarchio, Chiara Zagni, Rita Turnaturi, Sandro Dattilo, Vincenzo Patamia, Giuseppe Floresta, Sabrina Carola Carroccio, Tommaso Mecca, Antonio Rescifina.

A Full Carbon-Based Thermoplastic Photocatalyst for Organic Pollutants Abatement: An Experimental and Computational Study
FlatChem
January 2025 | Journal article
Contributors: Lidia Mezzina, Angelo Nicosia, Vincenzo Patamia, Antonio Rescifina, Luisa D’Urso, Vincenzo Paratore, Placido Giuseppe Mineo.

Enhancing HDAC Inhibitor Screening: Addressing Zinc Parameterization and Ligand Protonation in Docking Studies
International Journal of Molecular Sciences
January 20, 2025 | Journal article
Contributors: Rocco Buccheri, Alessandro Coco, Lorella Pasquinucci, Emanuele Amata, Agostino Marrazzo, Antonio Rescifina.

Bio-Based Palladium Catalyst in Cryogel for Cross-Coupling Reactions
Materials Chemistry Frontiers
2024 | Journal article
Contributors: Elisabetta Grazia Tomarchio, Chiara Zagni, Vincenzo Paratore, Guglielmo Guido Condorelli, Sabrina Carola Carroccio, Antonio Rescifina.

 

 

Mr. Xiaogang Liu | Molecular Biology | Best Researcher Award

Mr. Xiaogang Liu | Molecular Biology | Best Researcher Award

Beijing Institute of Technology, China.

Dr. Xiaogang Liu is a dedicated Lecturer at the Zhuhai Campus of Beijing Institute of Technology. With a strong foundation in Biochemistry and Molecular Biology, he specializes in Chemical Biology. His research primarily focuses on Computational Chemistry to study pH-Responsive Fluorescent Probes and develop related software. In addition to his research contributions, he is passionate about teaching and mentoring students in the areas of Molecular Biology and Immunology.

Profile

Orcid

Education 🎓

Xiaogang Liu earned his Bachelor’s Degree in Biochemistry from Shanxi University, where he laid the groundwork for his extensive studies in the fields of Biochemistry and Molecular Biology. During his time at Shanxi University, he gained a solid understanding of the core principles of biochemical processes and molecular interactions, which set the stage for his later academic pursuits. His education at Shanxi University sparked his passion for Chemical Biology, ultimately shaping his career in research and teaching.

Experience 💼

Dr. Liu has taken on multiple roles in research and academia. Currently, as a Lecturer at Beijing Institute of Technology, he actively teaches and supervises students while also conducting research in Bioinformatics and Chemical Biology. His work focuses on exploring computational methodologies to understand complex chemical systems and biological molecules.

Research Interests 🔬

Chemical Biology: Investigating pH-Responsive Fluorescent Probes

Computational Chemistry: Developing software to support chemical biology research

Bioinformatics: Exploring the intersection of biology and computing to enhance molecular biology applications
Dr. Liu's research also delves into the integration of Computational Chemistry and Chemical Biology to advance understanding in fields like fluorescence sensing, probe design, and software development.

Selected Publications 📚

Computational Chemistry Study of pH-Responsive Fluorescent Probes and Development of Supporting Software
Journal: Molecules (2025), Volume: 30(2), Article 273
Contributors: Xiaogang Liu

Large Scale Virtual Screening for Finding Inhibitor against the RNA-dependent RNA Polymerase from Herbal Medicine for SARS-Cov-2 Therapy
Proceedings of the 11th International Conference on Biomedical Engineering and Bioinformatics (2022)
Contributors: Xiaogang Liu, Zirong Liang, Shiye Wu, Ying Wang, Binquan Gou

Virtual Screening for Finding Inhibitor Against the Main Protease of SARS-Cov-2 from the FDA-Approved Drugs Database
International Conference on Biomedical and Intelligent Systems (IC-BIS 2022) (2022-12-06)
Contributors: Xiaogang Liu, Shiye Wu, Zitong Zhu, Ying Wang, Binquan Gou

Teaching Reform and Application of Cell Biology in Bioengineering Specialty
Science & Technology Information (2021-12-13)
Contributors: Xiaogang Liu

 

 

Dr. Chen Cui | Biochemistry | Best Researcher Award

Dr. Chen Cui | Biochemistry | Best Researcher Award

Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-Sen University, China

Cui Chen, an Assistant Researcher at the Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-Sen University, specializes in the development and regeneration of orofacial bones. With a focus on mesenchymal stem cells and their role in bone remodeling and tooth eruption, Cui has contributed extensively to the understanding of mandibular growth and alveolar bone formation. His impactful research includes high-impact publications and innovative findings in the field of stomatology.

Profile

Scopus

Orcid

Education 🎓

Dr. Chen Cui earned his Ph.D. in Stomatology from Sichuan University (2017–2020), where he conducted in-depth research on orofacial bone development and mesenchymal stem cell mechanisms in mandibular growth. Prior to this, he completed his Bachelor of Dental Surgery (BDS) at Sichuan University (2012–2017), gaining a strong foundation in dental sciences and clinical practice. His academic journey has been marked by a commitment to advancing knowledge in stomatology and regenerative dentistry.

Experience 💼

Dr. Chen  currently serves as an Assistant Researcher at the Hospital of Stomatology, Sun Yat-Sen University (2020–Present), where he focuses on groundbreaking studies in orofacial bone development and regeneration. Previously, he was a Postdoctoral Research Fellow at the same institution (2020–2022), during which he contributed significantly to projects exploring the molecular and cellular mechanisms underlying bone formation and repair. His roles demonstrate a continuous trajectory of excellence and dedication to advancing dental and craniofacial research.

Research Interests 🔬

Development and Regeneration of Orofacial Bones 🦷

Chen Cui's research delves deeply into the intricate processes of orofacial bone development and regeneration. His work aims to unravel the cellular and molecular pathways that govern the growth, repair, and restoration of craniofacial structures, addressing critical challenges in dental and craniofacial health.

Mechanisms of Mesenchymal Stem Cells in Bone and Tooth Formation 🔬

A significant focus of his studies is on mesenchymal stem cells (MSCs) and their pivotal role in the formation of bones and teeth. By exploring how MSCs contribute to tissue differentiation and regeneration, Chen Cui seeks to enhance therapeutic strategies for bone and dental restoration.

Alveolar Bone Remodeling in Inflammatory Environments 🌟

Chen Cui has investigated the impact of inflammation on alveolar bone remodeling, shedding light on how environmental factors influence bone integrity. His findings offer insights into improving treatment outcomes for conditions like periodontitis and bone loss associated with inflammatory disorders.

The Role of Parathyroid Hormone Signaling in Dental Development 🧬

Exploring the parathyroid hormone (PTH) signaling pathway, Chen Cui has identified its critical role in regulating dental development and tooth eruption. His research on PTH signaling contributes to a deeper understanding of bone health and has implications for treating dental anomalies and diseases.

Awards & Recognitions 🏆

Recipient of the National Natural Science Foundation of China Grant

Funded by the China Postdoctoral Science Foundation

Recognized by the Guangdong Basic and Applied Basic Research Foundation

Publications Top Notes 📚

PTH1R Suppressed Apoptosis of Mesenchymal Progenitors in Mandibular Growth (2024), International Journal of Molecular Sciences. Link

Klotho in Osx+ Mesenchymal Progenitors Exerts Pro-Osteogenic Effects (2022), Signal Transduction and Targeted Therapy. Cited by: 28. Link

Dental Follicle Progenitor/Stem Cells: Mechanisms to Applications (2021), Biomolecules. Cited by: 34. Link

Fibrocartilage Stem Cells in Temporomandibular Joints (2021), Frontiers in Cell and Developmental Biology Cited by: 9. Link

Role of PTH1R Signaling in Prx1+ Mesenchymal Progenitors during Eruption (2020), Journal of Dental Research Cited by: 27. Link